Compare Cytokinetics Inc (CYTK) vs Infosys Limited (INFY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Infosys Limited — how do they compare? Cytokinetics Inc trades at $76.61 (market cap $10.63B), while Infosys Limited trades at $12.37 (market cap $50.55B). The key difference: Infosys Limited is far larger — about 4.8× Cytokinetics Inc's market cap, and Infosys Limited pays a 4.16% dividend while Cytokinetics Inc pays none. Which is the better fit depends on your goals.
| CYTK | INFY | |
|---|---|---|
Market Cap | $10.63B | $50.55B |
Sector | Technology | Technology |
52-Week High | $87.26 | $20.22 |
52-Week Low | $34.31 | $10.49 |
Enterprise Value | $10.74B | $48.30B |
Dividend Yield | — | 4.16% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Infosys Limited
Infosys is a global leader in next-generation digital services and consulting. It enables clients in more than 50 countries to navigate their digital transformation through AI-powered cloud and data solutions.
Read more on INFY →
